Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Mayne Pharma, priced at $2.0089 per EA under NDC 51862017901. Its NADAC has been published 633 times since Nov 28, 2013.
FDA first approved this application on Mar 17, 1986. Its Orange Book therapeutic-equivalence code is AA.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE
butalbital, acetaminophen and caffeineStrength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Mayne PharmaNDC
51862017901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA089007FDA Approved
3/17/1986
TE Code
AA
On Market Since
4/16/2012
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has been published 633 times since Nov 28, 2013, and over the history we have for it it has risen 259.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0089 per EA |
|---|---|
| All-time high | $3.8847 (May 15, 2019) |
| All-time low | $0.2999 (Mar 18, 2015) |
| 52-week high | $2.3000 |
| 52-week low | $1.6931 |
| Median price | $2.2931 |
| Average price | $2.2989 |
| Largest weekly change | +397.0% (May 20, 2015) |
| Weeks tracked | 633 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Mayne Pharma, is $2.0089 per EA (NDC 51862017901), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has risen 259.1%. It has been tracked across 633 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
Since Nov 28, 2013, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $0.2999 (Mar 18, 2015) to a high of $3.8847 (May 15, 2019), with a median of $2.2931 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE, is $1.6931 per EA — about 16% below BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE (NDC 51862017901) is labeled by Mayne Pharma, and CMS classifies it as a generic product.